Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English | Polski
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Linakis, Matthew W."" wg kryterium: Autor

  Lista filtrów

Ogranicz do:

Wyrównaj
Wyświetlanie 1-20 z 49
Podgląd okładki
Tytuł :
Development and evaluation of a high throughput inhalation model for organic chemicals
Autorzy :
Linakis, Matthew W.Aff1, Aff2
Sayre, Risa R.Aff3, Aff4
Pearce, Robert G.Aff3, Aff4
Sfeir, Mark A.Aff3, Aff4
Sipes, Nisha S.
Pangburn, Heather A.
Gearhart, Jeffery M.Aff1, Aff7
Wambaugh, John F.
Pokaż więcej
Źródło :
Journal of Exposure Science & Environmental Epidemiology: Official journal of the International Society of Exposure Science. 30(5):866-877
Czasopismo naukowe
Szczegóły
Podgląd okładki
Tytuł :
Stability of Oxandrolone in Medium-Chain Triglyceride Oil and Pharmacokinetics Following Buccal Administration of the Extemporaneous Formulation in Neonates and Adults.
Autorzy :
Linakis, Matthew W.
Rower, Joseph E.
Sorenson, Susan
Reilly, Christopher A.
Lambert, Linda M.
Williams, Richard V.
Burch, Phillip T.
Pokaż więcej
Źródło :
Journal of Pediatric Pharmacology & Therapeutics. 2020, Vol. 25 Issue 3, p220-227. 8p.
Czasopismo naukowe
Szczegóły Pełny tekst
Podgląd okładki
Tytuł :
Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study
Autorzy :
Linakis, Matthew W.Aff1, Aff2
Cook, Sarah F.
Kumar, Shaun S.
Liu, Xiaoxi
Wilkins, Diana G.Aff4, Aff5
Gaedigk, Roger
Gaedigk, Andrea
Sherwin, Catherine M. T.Aff1, Aff2
van den Anker, John N.Aff7, Aff8
Pokaż więcej
Źródło :
Clinical Pharmacokinetics. 57(10):1325-1336
Czasopismo naukowe
Szczegóły
Podgląd okładki
Tytuł :
Correction: Development and evaluation of a high throughput inhalation model for organic chemicals.
Autorzy :
Linakis MW; United States Air Force, 711th Human Performance Wing, Airman Readiness Optimization, Wright-Patterson AFB, Wright-Patterson AFB, OH, 45433, USA.; UES, Inc., Dayton, OH, 45432, USA.
Sayre RR; Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37831, USA.; National Center for Computational Toxicology, United States Environmental Protection Agency, Research Triangle Park, NC, 27711, USA.
Pearce RG; Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37831, USA.; National Center for Computational Toxicology, United States Environmental Protection Agency, Research Triangle Park, NC, 27711, USA.
Sfeir MA; Oak Ridge Institute for Science and Education, Oak Ridge, TN, 37831, USA.; National Center for Computational Toxicology, United States Environmental Protection Agency, Research Triangle Park, NC, 27711, USA.
Sipes NS; National Institute of Environmental Health Sciences, Research Triangle Park, NC, 27711, USA.
Pangburn HA; United States Air Force, 711th Human Performance Wing, Molecular Bioeffects, Wright-Patterson AFB, Wright-Patterson AFB, OH, 45433, USA.
Gearhart JM; United States Air Force, 711th Human Performance Wing, Airman Readiness Optimization, Wright-Patterson AFB, Wright-Patterson AFB, OH, 45433, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Wright-Patterson AFB, Wright-Patterson AFB, OH, 45433, USA.
Wambaugh JF; National Center for Computational Toxicology, United States Environmental Protection Agency, Research Triangle Park, NC, 27711, USA. .
Pokaż więcej
Źródło :
Journal of exposure science & environmental epidemiology [J Expo Sci Environ Epidemiol] 2020 Sep; Vol. 30 (5), pp. 898.
Typ publikacji :
Published Erratum
Szczegóły
Podgląd okładki
Tytuł :
Predicting tacrolimus concentrations in children receiving a heart transplant using a population pharmacokinetic model.
Autorzy :
Rower JE; Department of Pediatrics, Division of Clinical Pharmacology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Stockmann C; Department of Pediatrics, Division of Clinical Pharmacology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Linakis MW; Department of Pediatrics, Division of Clinical Pharmacology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Kumar SS; Department of Pediatrics, Division of Clinical Pharmacology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Liu X; Department of Pediatrics, Division of Clinical Pharmacology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Korgenski EK; Pediatric Clinical Program, Intermountain Healthcare, Salt Lake City, Utah, USA.
Sherwin CMT; Department of Pediatrics, Division of Clinical Pharmacology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, Utah, USA.
Molina KM; Primary Children's Hospital, Intermountain Healthcare, Salt Lake City, Utah, USA.; Department of Pediatrics, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Pokaż więcej
Źródło :
BMJ paediatrics open [BMJ Paediatr Open] 2017; Vol. 1, pp. e000147. Date of Electronic Publication: 2017 Nov 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Szczegóły
Podgląd okładki
Tytuł :
Challenges Associated with Route of Administration in Neonatal Drug Delivery.
Autorzy :
Linakis MW; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84108, USA.; Department of Pharmaceutical Chemistry, University of Utah, School of Pharmacy, Salt Lake City, UT, USA.
Roberts JK; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84108, USA.
Lala AC; Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Spigarelli MG; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84108, USA.
Medlicott NJ; School of Pharmacy, University of Otago, Dunedin, New Zealand.
Reith DM; Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Ward RM; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84108, USA.; Division of Neonatology, Department of Pediatrics, University of Utah, School of Medicine, Salt Lake City, UT, USA.; Department of Pharmacology/Toxicology, University of Utah College of Pharmacy, Salt Lake City, UT, USA.
Sherwin CM; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84108, USA. .
Pokaż więcej
Źródło :
Clinical pharmacokinetics [Clin Pharmacokinet] 2016 Feb; Vol. 55 (2), pp. 185-96.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Delivery Systems*
Drug Administration Routes ; Humans ; Infant, Newborn ; Pharmaceutical Preparations/administration & dosage
Czasopismo naukowe
Szczegóły
Podgląd okładki
Tytuł :
Quantitative Assay Validation for Oxandrolone in Human Plasma Using LC-MS-MS.
Autorzy :
Linakis MW; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah, 295 Chipeta Way, Suite 1S100, Salt Lake City, UT 84108, USA Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, 30 S 2000 E Salt Lake City, UT 84112, USA.
Stockmann C; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah, 295 Chipeta Way, Suite 1S100, Salt Lake City, UT 84108, USA Department of Pharmacology and Toxicology, University of Utah, 30 S 2000 E Salt Lake City, UT 84112, USA.
Campbell SC; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah, 295 Chipeta Way, Suite 1S100, Salt Lake City, UT 84108, USA.
Williams RV; Division of Pediatric Cardiology, Department of Pediatrics, University of Utah, 100 N Mario Capecchi Drive, Suite 1500, Salt Lake City, UT 84113, USA.
Burch PT; Division of Cardiothoracic Surgery, Department of Surgery, University of Utah, 100 N Mario Capecchi Drive, Suite 2800, Salt Lake City, UT 84113, USA.
Lambert LM; Division of Cardiothoracic Surgery, Department of Surgery, University of Utah, 100 N Mario Capecchi Drive, Suite 2800, Salt Lake City, UT 84113, USA.
Sherwin CM; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah, 295 Chipeta Way, Suite 1S100, Salt Lake City, UT 84108, USA.
Reilly CA; Department of Pharmacology and Toxicology, University of Utah, 30 S 2000 E Salt Lake City, UT 84112, USA.
Spigarelli MG; Division of Clinical Pharmacology, Department of Pediatrics, University of Utah, 295 Chipeta Way, Suite 1S100, Salt Lake City, UT 84108, USA .
Pokaż więcej
Źródło :
Journal of analytical toxicology [J Anal Toxicol] 2015 Sep; Vol. 39 (7), pp. 526-31. Date of Electronic Publication: 2015 May 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Chromatography, High Pressure Liquid*/standards
Tandem Mass Spectrometry*/standards
Anabolic Agents/*blood
Oxandrolone/*blood
Calibration ; Drug Stability ; Female ; Humans ; Male ; Predictive Value of Tests ; Reference Standards ; Reproducibility of Results
Czasopismo naukowe
Szczegóły
Podgląd okładki
Tytuł :
Pharmacokinetic considerations in the use of antivirals in neonates.
Autorzy :
Enioutina EY; a Division of Clinical Pharmacology, Department of Pediatrics , University of Utah School of Medicine , 295 Chipeta Way, Salt Lake City , UT 84108 , USA.; b Division of Microbiology and Immunology, Department of Pathology , University of Utah School of Medicine , 15 North Medical Drive East, Salt Lake City , UT 84112 , USA.
Constance JE; a Division of Clinical Pharmacology, Department of Pediatrics , University of Utah School of Medicine , 295 Chipeta Way, Salt Lake City , UT 84108 , USA.
Stockmann C; a Division of Clinical Pharmacology, Department of Pediatrics , University of Utah School of Medicine , 295 Chipeta Way, Salt Lake City , UT 84108 , USA.
Linakis MW; a Division of Clinical Pharmacology, Department of Pediatrics , University of Utah School of Medicine , 295 Chipeta Way, Salt Lake City , UT 84108 , USA.
Yu T; a Division of Clinical Pharmacology, Department of Pediatrics , University of Utah School of Medicine , 295 Chipeta Way, Salt Lake City , UT 84108 , USA.
Rower JE; a Division of Clinical Pharmacology, Department of Pediatrics , University of Utah School of Medicine , 295 Chipeta Way, Salt Lake City , UT 84108 , USA.
Balch AH; a Division of Clinical Pharmacology, Department of Pediatrics , University of Utah School of Medicine , 295 Chipeta Way, Salt Lake City , UT 84108 , USA.
Sherwin CM; a Division of Clinical Pharmacology, Department of Pediatrics , University of Utah School of Medicine , 295 Chipeta Way, Salt Lake City , UT 84108 , USA.
Pokaż więcej
Źródło :
Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2015; Vol. 11 (12), pp. 1861-78. Date of Electronic Publication: 2015 Nov 04.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiviral Agents/*pharmacokinetics
Immune System/*physiology
Virus Diseases/*drug therapy
Adult ; Age Factors ; Animals ; Antiviral Agents/administration & dosage ; Child ; Disease Susceptibility/immunology ; Dose-Response Relationship, Drug ; Humans ; Infant, Newborn ; Infant, Premature ; Virus Diseases/epidemiology ; Virus Diseases/immunology
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 49

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies